EC-0652

Star0

DB15340ExperimentalSmall molecule

EC-0652 is under investigation in clinical trial NCT02202447 (Phase 1 of EC1169 In Patients With Recurrent MCRPC).

Formula / weight: C₄₇H₆₅N₉O₁₇S · 1060.14 g/mol (avg)
Code names: EC0652

Resolves to

Compound

UNIIRWY5U5KZV3CAS1025066-50-5

Structure

InChIKeyVHRCAJFLDBPRPG-POFDKVPJSA-NSMILES

N[C@@H](CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CCCCCCCNC(=O)CC[C@H](NC(=O)N[C@@H](CCC(O)=O)C(O)=O)C(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CS)C(O)=O

Which companies are running trials of EC-0652, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account